Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A New Wave of Targeting ‘Undruggable’ Wnt Signaling for Cancer Therapy: Challenges and Opportunities
Woo Jung Park, Moon Jong Kim
Cells (2023) Vol. 12, Iss. 8, pp. 1110-1110
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment
William H. Gmeiner
Cancers (2024) Vol. 16, Iss. 5, pp. 1029-1029
Open Access | Times Cited: 16
Current advances and development strategies of orally bioavailable PROTACs
Shenxin Zeng, Yingqiao Ye, Heye Xia, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115793-115793
Closed Access | Times Cited: 35
Targeted Treatment against Cancer Stem Cells in Colorectal Cancer
Julia Martínez-Pérez, C. Sevillano, Maria A Dominguez-Cejudo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6220-6220
Open Access | Times Cited: 10
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Jennifer Haynes, Prasath Manogaran
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1988-1988
Open Access
Transcriptomic Profiles for Elucidating Response of Bladder Intracavitary Hyperthermic Perfusion Chemotherapy in High‐Risk Nonmuscular Invasive Bladder Cancer
Zhicheng Huang, Tianhui Zhang, Jinghua Pan, et al.
Cancer Medicine (2025) Vol. 14, Iss. 4
Open Access
When You Come to a Fork in the Road, Take It: Wnt Signaling Activates Multiple Pathways through the APC/Axin/GSK-3 Complex
Chenchen Li, Emma E. Furth, Anil K. Rustgi, et al.
Cells (2023) Vol. 12, Iss. 18, pp. 2256-2256
Open Access | Times Cited: 9
A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)
David R. Wise, Russell K. Pachynski, Samuel R. Denmeade, et al.
Prostate Cancer and Prostatic Diseases (2024)
Open Access | Times Cited: 2
Altered lipid metabolism in APC-driven colorectal cancer: the potential for therapeutic intervention
Courtney O. Kelson, Yekaterina Y. Zaytseva
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Canonical WNT/β-catenin signaling upregulates aerobic glycolysis in diverse cancer types
Meetu Rathee, Sheikh Mohammad Umar, Arundhathi Dev, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 2
WNT5A is a putative epi‐driver of prostate cancer metastasis to the bone
E. J. Wilkinson, Kelsie Raspin, RC Malley, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 2
Belling the “cat”: Wnt/β-catenin signaling and its significance in future cancer therapies
Atul Kumar Goyal, Satyajit Laxman Murkute, Sujoy Bhowmik, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189195-189195
Closed Access | Times Cited: 2
Unlocking the role of non-coding RNAs in prostate cancer progression: exploring the interplay with the Wnt signaling pathway
Tong Bu, Le Li, Jiyu Tian
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
The role of YAP/TAZ mechanosignaling in trabecular meshwork and Schlemm’s canal cell dysfunction
Rajanya Ghosh, Samuel Herberg
Vision Research (2024) Vol. 224, pp. 108477-108477
Closed Access | Times Cited: 1
Structural and Functional Insights into Dishevelled-Mediated Wnt Signaling
Lei Wang, Rui Zhu, Zehua Wen, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1870-1870
Open Access | Times Cited: 1
Identifying colorectal cancer-specific vulnerabilities in the Wnt-driven long non-coding transcriptome
Laura Schwarzmueller, R. Adam, Leandro F. Moreno, et al.
Gut (2024), pp. gutjnl-332752
Open Access | Times Cited: 1
Therapeutic Potential of Natural Compounds to Modulate WNT/β-Catenin Signaling in Cancer: Current State of Art and Challenges
Anna Gajos-Michniewicz, Małgorzata Czyż
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12804-12804
Open Access | Times Cited: 1
A phase I dose-escalation study of LRP5/6 antagonist BI 905677 in patients with advanced solid tumors
Heinz‐Josef Lenz, Guillem Argilés, Maja J.A. de Jonge, et al.
ESMO Open (2024) Vol. 9, Iss. 11, pp. 103729-103729
Open Access | Times Cited: 1
Molecular glue degrader for tumor treatment
Yuhan Hu, Yan Yan, Jiehao Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Zebrafish drug screening identifies Erlotinib as an inhibitor of Wnt/β-catenin signaling and self-renewal in T-cell acute lymphoblastic leukemia
Majd A. Al-Hamaly, Anna H. Cox, Meghan G. Haney, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116013-116013
Open Access | Times Cited: 2
In silico identification and in vitro validation of alpha-hederin as a potent inhibitor of Wnt/β-catenin signaling pathway in breast cancer stem cells
Tolulope Peter Saliu, Nirwani Natasha Seneviratne, Mishal Faizan, et al.
In Silico Pharmacology (2024) Vol. 12, Iss. 1
Closed Access
Incidence of RSPO3 rearrangements in advanced colorectal cancer patients detected by NGS and their relationship with disease characteristics
Raquel Tur, Mar Abad, Elena Filipovich, et al.
Research Square (Research Square) (2024)
Open Access
GPA33 expression in colorectal cancer can be induced by WNT inhibition and targeted by cellular therapy
Teresa Börding, Tobias Janik, Philip Bischoff, et al.
Oncogene (2024) Vol. 44, Iss. 1, pp. 30-41
Closed Access
Emerging therapeutic strategies for Wnt-dependent colon cancer targeting macropinocytosis
Nydia Tejeda‐Muñoz, Grace Binder, Kuo‐Ching Mei
Cells and Development (2024) Vol. 180, pp. 203974-203974
Open Access
Boronic Acid-Containing 3H- pyrazolo[4,3-f]quinoline Compounds as Dual CLK/ROCK Inhibitors with Anticancer Properties
Neetu Dayal, Riddhi Chaudhuri, Kofi S. Yeboah, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1660-1660
Open Access
Wnt-Regulated Therapeutics for Blood-Brain Barrier Modulation and Cancer Therapy
Pei An, Yang Tong, Rui Mu, et al.
Bioconjugate Chemistry (2024)
Closed Access
Page 1 - Next Page

Scroll to top